News Conference News EuroPCR 2012 No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES By Caitlin E. Cox May 18, 2012
News Conference News ACC 2012 Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES By L.A. McKeown March 26, 2012
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome By Caitlin E. Cox May 18, 2012
News Conference News EuroPCR 2012 FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy By Caitlin E. Cox May 15, 2012
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism By L.A. McKeown March 26, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding By L.A. McKeown March 24, 2012
News Conference News EuroPCR 2012 Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations By Jason Kahn May 15, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES By Jason Kahn March 24, 2012
News Conference News ACC 2012 PARTNER: TAVR Remains as Effective as Surgery at 2 Years March 26, 2012